Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D A Q&A with iXCells Biotechnologies CEO, Steve Smith February 25, 2026 9 min The Medicine Maker Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions